Recombinant Human gp130

Glycoprotein 130 (gp130), also known as IL6ST, IL6β and CD130), is a transmembrane protein and belongs to the class I cytokine receptor family. It is often referred to as the common gp130 subunit, shared by the functional receptor complexes of IL-6, IL-11, leukemia inhibitory factor (LIF), granulocyte colonystimulating factor, ciliary neurotrophic factor and cardiotrophin-1 (1). gp130 binds to IL-6/IL-6Rα complex, resulting in the formation of high-affinity IL-6 binding sites. This complex of three proteins then homodimerizes to form a hexameric complex which can produce downstream signals. gp130 signals are mediated by tyrosine kinases of the JAK family and by their binding partners, transcription factors of the STAT family (2). In addition, gp130 signaling is very important for osteoblast function and calcium homeostasis (3). gp130 is found in tissues such as brain, heart, thymus, spleen, kidney, lung and liver. It is involved in various human diseases, such as liver disease, coronary artery disease and myocardial infarction. Furthermore, gp130 is widely expressed in breast cancer cell lines and primary tumors, thus it has been implicated in constitutive STAT3 activation in breast cancer (4). Knockout studies in mice suggested a critical role of gp130 as the mice develop a broad spectrum of hematopoietic abnormalities, including splenomegaly, lymphadenopathy and thrombocytosis.

The biological activity of Human gp130 was determined by its ability to inhibit the IL-6 sR enhancement of IL-6 activity on a mouse myeloid leukemia cell line, M1 (Saito, T. et al., 1991, J. Immunol. 147:168). The expected ED₅₀ for this effect is typically 0.5-2 μg/ml in the presence of 10 ng/ml rhIL-6 sR and 20 ng/ml rhIL-6.

lldpcgy ispespvvql hsnftavcvl kekcmdyfhv nanyivwktn hftipkeqyt iinrtassvt ftdiaslniq ltcniltfgq leqnvygiti isglppekpk nlscivnegk kmrcewdggr ethletnftl ksewathkfa dckakrdtpt sctvdystvy fvnievwvea enalgkvtsd hinfdpvykv kpnpphnlsv inseelssil kltwtnpsik sviilkyniq yrtkdastws qippedtast rssftvqdlk pfteyvfrir cmkedgkgyw sdwseeasgi tyedrpskap sfwykidpsh tqgyrtvqlv wktlppfean gkildyevtl trwkshlqny tvnatkltvn ltndrylatl tvrnlvgksd aavltipacd fqathpvmdl kafpkdnmlw vewttpresv kkyilewcvl sdkapcitdw qqedgtvhrt ylrgnlaesk cylitvtpvy adgpgspesi kaylkqapps kgptvrtkkv gkneavlewd qlpvdvqngf irnytifyrt iignetavnv dsshteytls sltsdtlymv rmaaytdegg kdgpeftftt pkfaqgeie

Leu24

Lyophilized

The predicted molecular weight of Recombinant Human gp130 is Mr 68 kDa.

68

This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.

This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Next Day Ambient

1. Bravo, J. et al. (1998) EMBO J 17: 1665
2. Graeve, L et al. (1998) Biochem J 334: 297
3. Kronenber, HM. et al. (2004) Endocrinology 145: 1376